Associated factors and perinatal outcomes of placenta accreta spectrum

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220812003

Enrollment

Registered

2022-08-12

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal morbidities including total operative time, total blood loss, total blood transfusion, early PPH and duration of hospital stay increased significantly. Neonatal morbidities including preterm delivery, small gestational age, mild birth asphyxia, need for PPV, need for oxygen support on ETT or NICU admission increased Placenta accreta spectrum, PAS, perinatal outcome, maternal outcome

Interventions

pregnant women of gestational age more than 20 weeks who delivered at Srinagarind Hospital and were diagnosed with placenta accreta spectrum using histopathological criteria, control groups were match

Other,Other

PAS Group,Control Group

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: pregnant women of gestational age more than 20 weeks who delivered at Srinagarind Hospital and were diagnosed with placenta accreta spectrum using histopathological criteria

Exclusion criteria

Exclusion criteria: incomplete medical record data

Design outcomes

Primary

Measure	Time frame
associated factors of placenta accreta spectrum 12 month matched case-control study, matched by gestational age and number of prior cesarean sections	—

Secondary

Measure	Time frame
perinatal outcomes. 12 month matched case-control study, matched by gestational age and number of prior cesarean sections	—

Countries

Thailand

Contacts

Public ContactSiraporn Subin

Faculty of Medicine, Khon Kaen University

ssbeejah30@gmail.com0859286010

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026